Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
2.02%
0%
2.02%
6 Months
10.35%
0%
10.35%
1 Year
23.09%
0%
23.09%
2 Years
14.35%
0%
14.35%
3 Years
43.1%
0%
43.1%
4 Years
37.39%
0%
37.39%
5 Years
25.33%
0%
25.33%
Canature Health Technology Group Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
8.85%
EBIT Growth (5y)
4.13%
EBIT to Interest (avg)
6.62
Debt to EBITDA (avg)
0.63
Net Debt to Equity (avg)
0.18
Sales to Capital Employed (avg)
0.78
Tax Ratio
14.34%
Dividend Payout Ratio
106.81%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.55%
ROE (avg)
9.55%
Valuation key factors
Factor
Value
P/E Ratio
37
Industry P/E
Price to Book Value
3.87
EV to EBIT
26.90
EV to EBITDA
18.88
EV to Capital Employed
3.64
EV to Sales
2.87
PEG Ratio
NA
Dividend Yield
1.60%
ROCE (Latest)
13.54%
ROE (Latest)
10.38%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
417.60
405.50
2.98%
Operating Profit (PBDIT) excl Other Income
44.30
73.30
-39.56%
Interest
10.70
7.90
35.44%
Exceptional Items
-1.10
-0.00
Consolidate Net Profit
12.80
33.90
-62.24%
Operating Profit Margin (Excl OI)
106.20%
133.40%
-2.72%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 2.98% vs 6.32% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is -62.24% vs 15.70% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,682.10
1,664.60
1.05%
Operating Profit (PBDIT) excl Other Income
239.00
233.70
2.27%
Interest
38.20
32.60
17.18%
Exceptional Items
-7.10
26.90
-126.39%
Consolidate Net Profit
113.40
153.50
-26.12%
Operating Profit Margin (Excl OI)
94.70%
92.80%
0.19%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 1.05% vs 0.60% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -26.12% vs 55.05% in Dec 2023
About Canature Health Technology Group Co., Ltd. 
Canature Health Technology Group Co., Ltd.
Industrial Manufacturing
No Details Available.
Company Coordinates 
No Company Details Available






